abl
track
donor
reactiv
cell
cours
organ
transplant
key
improv
graft
surviv
prevent
graft
dysfunct
adapt
immunosuppress
regimen
attempt
transplant
immunologist
long
hamper
larg
size
alloreact
cell
repertoir
understand
selftcr
interact
allogen
mhc
key
critic
apprais
differ
assay
avail
analyz
tcr
repertoir
usag
report
review
conceptu
experiment
process
crossreact
highlight
learn
allotransplant
situat
artifici
crossreact
final
lowand
highresolut
techniqu
character
tcr
repertoir
usag
transplant
critic
discuss
abl
track
donor
reactiv
cell
cours
organ
transplant
key
improv
graft
surviv
prevent
graft
dysfunct
adapt
immunosuppress
regimen
attempt
transplant
immunologist
long
hamper
larg
size
alloreact
cell
repertoir
understand
selftcr
interact
allogen
mhc
key
critic
apprais
differ
assay
avail
analyz
tcr
repertoir
usag
report
review
conceptu
experiment
process
crossreact
highlight
learn
allotransplant
situat
artifici
crossreact
final
lowand
highresolut
techniqu
character
tcr
repertoir
usag
transplant
critic
discuss
keyword
tcr
repertoir
transplant
crossreact
alloreact
tcr
mhc
cell
understand
crossreact
shape
lymphocyt
receptor
repertoir
evolut
numer
process
select
gener
divers
repertoir
abl
protect
mammalian
pathogen
insult
figur
highli
similar
gene
recombin
form
function
gene
gener
highli
divers
tcr
repertoir
chain
encod
distinct
variabl
v
trbv
divers
trbd
join
j
trbj
gene
wherea
chain
encod
distinct
set
v
j
gene
trav
traj
junction
diversif
extend
combinatori
divers
either
trim
gene
end
ad
nucleotid
recombin
gene
contrast
ighv
v
gene
immunoglobulin
heavi
chain
germlin
dataset
compil
immunogenet
imgt
group
greatli
benefit
advanc
deepsequenc
technolog
human
tcr
germlin
minim
chang
sinc
complet
sequenc
tcr
gene
loci
function
gene
orf
pseudogen
report
trbv
trav
trbd
dataset
analysi
tcr
still
challeng
process
identif
trbd
gene
figur
understand
crossreact
highli
divers
tcr
repertoir
highli
divers
repertoir
gener
iter
process
select
evolut
combinatori
divers
result
select
variabl
v
trav
trbv
divers
trbd
join
j
traj
trbj
gene
junction
diversif
extend
combinatori
divers
either
trim
gene
end
ad
nucleotid
recombin
gene
final
associ
chain
constitut
final
step
numer
iter
process
lead
gener
highli
divers
tcr
repertoir
abl
effici
protect
individu
pathogen
stimul
adopt
stereotyp
dock
geometri
atop
mhcpeptid
complex
orient
lead
spatial
interact
germlineencod
chain
edg
peptidegroov
mhc
accumul
report
crystallograph
structur
challeng
stereotyp
view
angl
tcr
dock
howev
recognit
conserv
motif
side
mhc
molecul
coreceptor
constrain
tcr
dock
geometri
despit
high
divers
tcr
repertoir
high
degre
crossreact
report
could
explain
natur
abil
tcr
interact
mhc
molecul
mhc
focu
model
well
interact
tcr
limit
number
amino
acid
peptid
bound
mhc
peptid
groov
march
volum
articl
frontier
immunolog
wwwfrontiersinorg
perform
due
high
degre
similar
trbd
end
short
length
two
gene
presenc
grich
n
nucleotid
end
could
also
ad
tdt
enzym
mislead
estim
combinatori
divers
simpli
multipli
togeth
number
v
j
gene
rather
random
combin
tcr
gene
studi
shown
tcr
gene
highli
bias
usag
part
theoret
divers
select
chromosom
recombin
pattern
explain
variat
enhanc
recombin
signal
sequenc
rss
organ
trbj
gene
block
six
seven
gene
locat
respect
downstream
gene
lead
bia
dj
pair
divers
tcr
repertoir
broaden
rearrang
process
first
addit
p
nucleotid
palindrom
nucleotid
thank
recombin
activ
form
hairpin
loop
gene
end
addit
n
nucleotid
bias
toward
g
nucleotid
termin
deoxynucleotidyl
transferas
tdt
insert
nucleotid
profound
impact
divers
complementarydetermin
region
sequenc
contribut
divers
code
end
gene
also
trim
exonucleas
howev
given
limit
number
amino
acid
remov
nucleotid
exonucleas
constrain
gener
product
codon
therefor
limit
contribut
exonucleas
trim
divers
tcr
repertoir
final
associ
chain
constitut
final
step
numer
iter
process
lead
gener
highli
divers
tcr
repertoir
abl
effici
protect
individu
pathogen
stimul
six
cdr
engag
peptidemhc
complex
endogen
exogen
peptid
present
respect
mhc
class
ii
molecul
mhc
class
groov
constrain
length
present
peptid
amino
acid
length
open
natur
peptidebind
cleft
mhc
class
ii
molecul
allow
broader
rang
peptid
present
hla
locu
polymorph
region
human
genom
variant
allel
hla
class
allel
hla
class
ii
allel
accord
imgthla
high
divers
hla
confer
almost
uniqu
signatur
hla
mankind
extend
combinatori
divers
result
associ
six
hla
class
two
allel
hlaa
b
cw
six
hla
class
ii
molecul
two
allel
hladr
dp
dq
high
mutat
level
hla
loci
preferenti
focus
peptidebind
cleft
cluster
variabl
amino
acid
sequenc
focu
mutat
underlin
function
hla
molecul
name
abl
display
larg
array
peptid
garcia
et
al
first
report
crystallograph
structur
murin
tcr
bound
peptidemhc
class
b
cytotox
cell
clone
one
wellcharacter
tcr
initi
isol
balbb
mous
allospecif
cell
recogn
l
mastocytoma
besid
primari
antigen
peptid
tcr
bind
differ
antigen
includ
siyr
also
show
adopt
diagon
orient
long
axi
peptid
orient
lead
spatial
interact
germlineencod
chain
edg
peptidegroov
mhc
figur
highli
divers
region
face
central
portion
bound
peptid
multipl
crystallograph
structur
tcrpeptid
mhc
complex
crystallograph
structur
tcr
repertoir
transplant
frontier
immunolog
wwwfrontiersinorg
obtain
reveal
dock
angl
tcr
conserv
stereotyp
posit
diagon
orient
long
axi
peptid
conserv
bind
model
lead
concept
tcr
mhc
hardwir
interact
result
coevolut
select
conserv
region
codon
lock
tcr
onto
mhc
molecul
stereotyp
orient
tcr
atop
mhc
molecul
howev
flexibl
initi
propos
accumul
crystal
structur
median
dock
angl
tcr
minmax
mhc
class
minmax
mhc
class
ii
figur
differ
theori
postul
explain
hardwir
tcr
mhc
molecul
includ
key
role
coreceptor
impos
steric
requir
concurr
associ
tcr
mhc
complex
allow
appropri
signal
event
occur
inde
main
role
coreceptor
recruit
src
tyrosin
kinas
lck
via
associ
cytoplasm
tail
lck
concentr
promot
phosphoryl
immunoreceptor
tyrosin
activ
motif
itam
cytoplasm
tail
subunit
initi
cascad
signal
event
lead
full
activ
lymphocyt
given
key
role
coreceptor
process
assum
abil
bind
respect
membraneproxim
domain
mhc
class
ii
molecul
protrud
loop
domain
mhc
class
molecul
constrain
dock
geometri
tcr
pmhc
figur
recent
report
bering
et
al
challeng
consensu
idea
highli
stereotyp
dock
tcr
atop
mhc
molecul
crystallograph
structur
two
tcr
bind
proinsulin
peptid
present
proinsulin
obtain
two
clone
induc
regulatori
cell
ternari
complex
reveal
polar
revers
compar
tcrpeptidemhc
complex
structur
remain
address
whether
singular
observ
could
generaliz
whether
revers
dock
uniqu
featur
regulatori
cell
whether
potenti
signal
differ
may
influenc
phenotyp
function
cell
crossreact
defin
abil
given
tcr
interact
one
pmhc
complex
differ
present
peptid
mhc
molecul
new
concept
present
earli
matzing
bevan
alloreact
cell
clone
deriv
owen
et
al
three
reactiv
allo
k
specif
k
self
sinc
numer
report
provid
evid
crossreact
instanc
mous
tcr
interact
syngen
mhc
b
present
siyr
allogen
present
allogen
studi
birnbaum
et
al
eleg
attempt
quantifi
crossreact
given
tcr
use
five
differ
tcr
clone
three
mous
origin
two
human
origin
high
throughput
screen
yeast
librari
deep
sequenc
author
demonstr
singl
tcr
interact
differ
peptid
jern
et
al
postul
cell
exhibit
uniqu
clonotyp
abl
recogn
one
antigen
mason
among
first
challeng
valid
clonal
select
theori
show
immun
system
highli
incompet
protect
individu
extern
insult
one
tcr
abl
recogn
singl
peptid
present
given
hla
context
cell
would
weigh
kg
would
need
provid
effici
coverag
potenti
foreign
peptid
clearli
state
immun
system
could
effici
protect
individu
one
tcr
interact
singl
antigen
unlik
affin
matur
b
cell
receptor
protein
sequenc
tcr
fix
naiv
cell
requir
recogn
foreign
antigen
encount
number
potenti
antigen
recogn
huge
given
variabl
induc
high
divers
peptidebind
groov
hla
class
ii
molecul
proteinogen
amino
acid
given
peptid
present
incred
high
number
peptid
potenti
gener
peptid
divers
extend
posttransl
modif
amino
acid
opinion
paper
andrew
sewel
elegantli
present
necess
crossreact
number
potenti
foreign
peptidemhc
complex
cell
might
encount
dwarf
number
tcr
avail
number
uniqu
estim
magnitud
mechan
describ
previous
gener
divers
envis
popul
level
given
rel
limit
number
gene
encod
tcr
chain
requir
tcr
recogn
highli
divers
hla
molecul
necess
cell
recogn
larg
array
peptid
expect
present
experiment
approach
aim
quantifi
number
peptid
recogn
singl
tcr
would
like
present
clear
evid
crossreact
involv
memori
cell
without
previou
antigen
encount
describ
year
ago
cell
memori
phenotyp
found
mice
cell
specif
ovalbumin
viral
antigen
hsv
vaccinia
could
detect
mice
despit
germfre
environ
despit
absenc
previou
antigen
encount
preexist
memori
cell
harbor
trait
memori
cell
abil
rapidli
prolifer
upon
stimul
secret
rapidli
proinflammatori
cytokin
homeostat
prolifer
age
crossrecognit
altern
ligand
postul
drive
accumul
memorylik
naiv
cell
observ
extend
human
set
cell
specif
cmv
herp
simplex
viru
hsv
epitop
identifi
healthi
volunt
never
infect
virus
cell
exhibit
memori
marker
also
memoryassoci
featur
rapid
prolifer
cytokin
secret
acquisit
memori
characterist
could
consequ
homeostat
prolifer
consequ
crossreact
antigen
environ
support
latest
hypothesi
su
et
al
shown
specif
cell
recogn
environment
peptid
present
gut
soil
bacteria
ocean
alga
plant
interest
cell
specif
even
purifi
cordblood
demonstr
therebi
presenc
cell
abl
recogn
self
nonself
antigen
newborn
interest
phenotyp
crossreact
cell
differ
newborn
adult
naiv
memori
phenotyp
respect
concept
clonal
delet
occur
thymu
challeng
aforement
report
compel
evid
suggest
evolutionari
perspect
necess
protect
individu
pathogen
far
import
limit
autoreact
recent
studi
davi
team
sustain
claim
frequenc
cell
specif
chromosom
specif
antigen
equival
hy
peptid
threefold
lower
man
compar
women
interest
wherea
cell
purifi
specif
regard
pool
six
self
peptid
prolifer
stimul
set
self
peptid
cell
specif
pool
six
nonself
peptid
exhibit
potent
prolif
respons
absenc
respons
report
selfspecif
cell
foreign
antigenspecif
cell
link
differ
genet
program
compar
clone
purifi
woman
lower
express
bclxl
thu
evolut
favor
absenc
hole
autoimmun
diseas
incid
may
seem
awkward
evolut
favor
escap
antiself
specif
cell
thymic
select
stringent
delet
antiself
cell
heavier
burden
maintain
toler
need
prevent
develop
autoimmun
diseas
howev
need
defend
immun
system
pathogen
especi
childhood
far
greater
need
prevent
autoimmun
popul
surviv
limit
delet
selfreact
cell
thank
larg
crossreact
cell
hole
cell
repertoir
pathogen
might
take
advantag
constrain
analysi
immun
system
monozygot
twin
enlighten
mani
aspect
studi
allow
dissoci
inborn
acquir
contribut
team
davi
recent
show
herit
b
cell
paramet
declin
rapidli
age
age
year
herit
explain
less
variat
b
cell
paramet
cmv
infect
protyp
exampl
influenc
nonherit
factor
whole
immun
system
inde
paramet
measur
discord
twin
influenc
cmv
infect
environ
carv
immun
system
singl
individu
past
immun
respons
heavili
imprint
present
immun
system
sinc
initi
observ
immun
cowpox
protect
individu
smallpox
numer
exampl
crossreact
report
mice
human
instanc
infect
bcg
influenza
viru
iav
lymphocyt
choriomening
viru
lcmv
murin
cytomegaloviru
mcmv
confer
level
protect
immun
vaccinia
viru
benefit
crossreact
panviru
protect
difficult
assess
obviou
reason
nevertheless
numer
exampl
singl
tcr
abl
recogn
differ
antigen
bcg
poxvirus
papillomaviru
coronaviru
influenza
viru
epsteinbarr
viru
larg
crossreact
cell
confer
effici
protect
cover
use
limit
number
cell
need
screen
incred
larg
array
peptid
present
mhc
molecul
besid
effici
use
limit
cell
resourc
crossreact
confer
spatiotempor
advantag
immun
system
scan
infect
cell
crossreact
could
also
envis
evolut
strategi
limit
immun
recognit
escap
recipi
immun
system
interact
foreign
hla
molecul
two
differ
circumst
pregnanc
transplant
thank
evolut
adapt
matern
immun
system
presenc
hla
mismatch
fetus
allorecognit
pregnanc
harm
could
even
benefici
mammalian
sexual
reproduct
immunolog
toler
toward
allogen
fetu
obtain
complex
network
regulatori
mechan
includ
lack
express
classic
mhc
class
molecul
placent
trophoblast
express
nonclass
mhc
class
hlae
hlag
surprisingli
hla
mismatch
propos
benefici
pregnanc
outcom
billington
report
placenta
larger
incompat
mous
compar
compat
fetus
hla
compat
fetus
ie
similar
matern
hla
shown
prone
abort
contrast
recipi
immun
system
potent
elimin
allogen
graft
absenc
immunosuppress
therapi
despit
absenc
thymic
central
select
potenti
graftrecipi
cell
allogen
mhc
motif
regard
abil
recogn
allogen
potenti
hla
larg
pool
cell
activ
donor
hla
molecul
either
direct
pathway
ie
donor
hla
present
donor
peptid
expect
process
foreign
mhc
molecul
coin
indirect
pathway
ie
recipi
hla
present
donor
peptid
transplant
immunologist
jargon
direct
allorecognit
pathway
repres
uniqu
exampl
function
effici
cross
reactiv
two
main
hypothes
postul
explain
basi
alloreact
emphas
role
either
mhc
molecul
peptid
polymorph
donor
mhc
molecul
could
act
innat
focu
lead
activ
unprim
recipi
cell
allopeptid
could
recogn
foreign
antigen
allogen
selfmhc
molecul
exhibit
high
degre
similar
figur
accord
mhc
centric
model
peptid
play
minor
role
process
alloreact
tcr
recogn
structur
determin
mhc
helic
syngen
allogen
mhc
bia
tcr
interact
mhc
molecul
support
theori
crystal
structur
allopmhc
complex
tcr
allogen
present
tcr
allogen
b
shown
alloreact
tcr
interact
allogen
mhc
similar
fashion
syngen
mhc
support
role
mhc
alloreact
report
hla
mismatch
donor
recipi
associ
wors
graft
surviv
other
lead
notion
taboo
mismatch
base
shape
rather
sequenc
differ
instanc
despit
singl
amino
acid
hla
class
antigen
mismatch
hlab
hlab
associ
transplant
reject
acut
graftversushost
diseas
peptid
repertoir
bound
hlab
hlab
shown
similar
howev
recent
report
challeng
observ
singl
amino
acid
mismatch
induc
present
uniqu
peptid
hlab
hlab
consist
stronger
cell
alloreact
observ
toward
hlab
compar
hlab
observ
support
notion
peptid
focu
tcr
allorecognit
line
molecular
mimicri
allorecognit
could
also
involv
crossreact
mhc
class
mhc
class
ii
even
xeno
mhc
schilman
et
al
report
cell
clone
could
activ
mhc
class
b
mhc
class
ii
ie
k
molecul
bydirect
recognit
cell
mhc
class
mhc
class
ii
report
later
observ
may
import
implic
attempt
minim
hla
mismatch
process
organ
alloc
use
mix
lymphocyt
reaction
shown
cell
peripher
blood
activ
mention
number
hla
mismatch
donor
recipi
primari
drive
forc
mobil
larger
fraction
cell
nomin
antigen
whether
alloreact
cell
activ
high
number
new
antigen
present
donor
hla
larg
number
differ
allophla
complex
still
debat
two
hypothes
mutual
exclus
indirect
pathway
enhanc
reactiv
recipi
cell
toward
allogen
graft
inde
peptid
present
mhc
molecul
deriv
predominantli
mhcrelat
molecul
introduct
donor
hla
molecul
thu
lead
introduct
great
pool
new
peptid
mobil
larg
fraction
recipi
cell
also
well
accept
memori
cell
gener
prior
transplant
constitut
major
hurdl
longterm
graft
accept
chronic
virus
ebv
cmv
induc
gener
larg
pool
memori
cell
instanc
memori
compart
blood
reactiv
hcmv
crossreact
virusspecif
cell
allogen
hla
extens
document
ebv
cmv
specif
cell
exhibit
frequent
crossreact
toward
allogen
mhc
class
complex
similar
observ
report
cell
specif
ebv
cmv
virusspecif
cell
crossreact
alloantigen
shown
experiment
model
prolifer
respons
transplant
allograft
vivo
instanc
lcmvspecif
cell
gener
infect
mice
armstrong
strain
lcmv
abl
vigor
prolifer
vivo
skin
transplant
ultim
mediat
skin
graft
reject
track
antidonor
respons
investig
tcr
repertoir
low
resolut
techniqu
high
throughput
sequenc
given
size
antidonor
cell
pool
great
effort
paid
track
immunerespons
use
analysi
tcr
repertoir
correl
specif
usag
tcr
repertoir
graft
statu
graft
outcom
present
avail
report
necessari
present
two
major
method
use
investig
tcr
usag
low
resolut
spectratyp
alon
tclandscap
combin
quantit
analysi
recent
high
resolut
deepsequenc
tcr
region
approach
figur
lowresolut
techniqu
base
analysi
length
region
wherea
highresolut
techniqu
identifi
sequenc
tcr
later
quantifi
abund
differ
cell
clone
tcr
famili
compos
cell
variou
length
region
distribut
length
assess
spectratyp
broad
spectrum
profil
identifi
rang
gaussianlik
profil
highli
restrict
profil
highlight
absenc
select
cell
expans
cell
clone
respect
differ
analyt
tool
use
character
length
distribut
qualit
assess
tcr
repertoir
complement
quantif
differ
famili
mrna
level
use
qrtpcr
cellular
level
use
flowcytometri
techniqu
still
offer
sever
benefit
higher
resolut
techniqu
cost
short
time
frame
obtain
result
gener
reason
amount
data
also
display
visibl
pattern
xray
global
tcr
alter
specif
patholog
context
rapid
survey
usag
tcr
repertoir
effici
perform
guid
investig
focus
target
tcr
famili
rang
resolut
spectrum
deepsequenc
tcr
obtain
full
pictur
usag
cell
repertoir
deep
ultradeep
resolut
avail
tcr
sequenc
allow
precis
apprais
distribut
differ
cell
clone
especi
across
differ
biolog
compart
furthermor
complet
tcr
sequenc
research
investig
similar
cell
figur
character
tcr
repertoir
low
resolut
high
resolut
techniqu
immun
challeng
lead
select
cell
harbor
specif
among
highli
divers
repertoir
antigenspecif
cell
could
identifi
lowresolut
techniqu
eg
spectratyp
highresolut
techniqu
eg
ng
lowresolut
techniqu
aim
identifi
famili
exhibit
monoclon
distribut
length
distribut
use
specif
pcr
spectratyp
clonal
identifi
famili
need
confirm
sequenc
pcr
product
cell
purif
enabl
later
perform
function
assay
reconstruct
order
identifi
recogn
antigen
deepsequenc
tcr
region
identifi
sequenc
tcr
intens
bioinformat
process
need
quantifi
abund
differ
cell
clone
given
burden
data
gener
nextgener
sequenc
wellfit
track
cell
clone
time
across
differ
anatom
site
march
volum
articl
frontier
immunolog
wwwfrontiersinorg
sequenc
biolog
compart
individu
take
advantag
public
repositori
databas
assess
specif
sequenc
potenti
reconstruct
tcr
order
search
recogn
peptid
howev
amount
data
gener
use
techniqu
extrem
high
effici
bioinformat
tool
specif
devot
analysi
need
identifi
meaning
inform
ocean
data
access
deepsequenc
like
broaden
near
futur
thank
advanc
bioinformat
tool
reduct
cost
tcr
repertoir
transplant
frontier
immunolog
wwwfrontiersinorg
lowresolut
techniqu
use
investig
usag
tcr
repertoir
kidney
transplant
recipi
variou
clinic
outcom
variou
time
point
posttransplant
use
combin
spectratyp
quantit
assess
tcr
transcript
abl
defin
direct
indirect
allorecognit
pattern
experi
model
allograft
congen
rat
use
approach
report
patient
biopsyproven
chronic
antibodymedi
camr
reject
exhibit
strong
alter
tcr
repertoir
correl
level
graft
lesion
classifi
banff
classif
contrast
oper
toler
patient
ie
patient
offimmunosuppress
month
wellfunct
graft
exhibit
polyclon
tcr
repertoir
larg
cohort
patient
stabl
graft
function
year
posttransplant
prospect
recruit
center
stringent
clinic
demograph
inclus
criteria
order
obtain
homogen
popul
nevertheless
could
highlight
usag
tcr
repertoir
highli
heterogen
rang
absenc
clonal
select
similar
oper
toler
accumul
select
cell
camr
reject
presenc
alter
tcr
repertoir
previous
report
rat
model
camr
similar
clone
could
identifi
blood
graft
larg
prospect
studi
kidney
transplant
recipi
stabl
graft
function
year
show
alter
tcr
repertoir
due
accumul
temra
cell
effector
memori
reexpress
cell
activ
profil
high
express
cytotox
molecul
perforin
perf
granzym
b
gzmb
tbet
abil
secret
interest
stabl
patient
increas
differenti
temra
cell
twofold
higher
risk
longterm
graft
dysfunct
note
use
similar
strategi
kim
et
al
recent
report
clonal
cell
could
evidenc
human
transplant
hand
sever
tcr
clonal
select
persist
least
day
among
day
surveil
collect
data
highlight
lowresolut
technic
provid
key
featur
accumul
select
cell
clone
use
monitor
kidney
transplant
recipi
major
drawback
spectratypebas
method
intrins
low
resolut
multipl
cell
clone
could
share
length
necessari
sequenc
tcr
chain
alter
length
distribut
assess
clonal
given
famili
howev
recent
compar
spectratyp
next
gener
sequenc
ng
techniqu
character
tcr
repertoir
blood
cerebr
spinal
fluid
csf
central
nervou
system
cn
patient
multipl
sclerosi
method
effici
highlight
similar
tcr
repertoir
csf
cn
tcr
clone
identifi
cn
also
found
csf
identifi
tcr
clone
use
blood
sampl
previous
discuss
size
donorreact
cell
repertoir
larg
constitut
limit
use
deepsequenc
approach
may
thu
naiv
approach
perform
ng
unfract
cell
aim
identifi
cell
clone
specif
given
situat
kidney
transplant
viral
infect
twostep
approach
need
first
step
purifi
cell
popul
interest
base
express
phenotyp
use
tetram
instanc
function
eg
cytokin
secret
prolifer
marker
indepth
character
tcr
cell
popul
interest
allow
definit
signatur
later
use
tag
unpurifi
sampl
analyz
approach
use
track
cmvor
bkspecif
cell
clone
alloreact
cell
first
report
hypothes
approach
transplant
context
publish
group
leventh
use
healthi
volunt
studi
aim
assess
breadth
clonal
structur
dynam
alloreact
cell
repertoir
day
mlr
prolifer
cell
purifi
accord
dilut
cell
divis
dye
compar
number
clone
cultur
prolifer
mlr
respond
two
type
alloreact
clone
identifi
low
ie
unobserv
precultur
sampl
cell
mlr
highabund
precultur
clone
ie
present
precultur
sampl
enrich
mlr
lowabund
clone
highabund
clone
detect
differ
experi
data
provid
new
evid
larg
size
alloreact
cell
pool
approach
use
recent
track
donorreact
cell
kidney
transplant
recipi
fingerprint
donorreact
cell
repertoir
establish
transplant
deepsequenc
prolifer
cell
day
mlr
fingerprint
donorreact
cell
monitor
later
transplant
without
need
perform
mlr
team
syke
provid
evid
toler
induct
protocol
base
combin
kidney
nonmyeloabl
bone
marrow
transplant
result
reduct
donoralloreact
cell
clone
howev
decreas
neither
observ
patient
fail
respond
toler
induc
protocol
patient
standard
immunosuppress
regimen
pretranspl
identif
donorreact
cell
clone
transplant
could
thu
mean
track
activ
immun
system
allogen
graft
studi
emerson
morri
show
antidonor
fingerprint
stabl
overtim
healthi
volunt
given
design
assay
preexist
clone
could
track
would
great
valu
compar
antidonor
clone
repertoir
transplant
start
time
direct
mlr
assay
investig
new
antidonor
cell
aris
transplant
inde
infect
occur
frequent
transplant
could
gener
virusspecif
cell
allogen
crossreact
potenti
moreov
prolifer
cell
day
mlr
per
se
donorspecif
prolifer
cell
could
also
link
bystand
stimul
transplant
immunologist
abl
track
rise
expans
donorspecif
cell
would
approach
wide
avail
use
clinic
manag
still
open
question
highthrough
put
techniqu
recent
emerg
certainli
import
step
forward
nevertheless
high
crossreact
cell
major
hurdl
identifi
trigger
expans
donorreact
cell
donor
antigen
viral
peptid
environment
antigen
lead
select
donorspecif
cell
promis
studi
tcr
alter
overcom
doubl
difficulti
offer
access
technic
present
data
valid
correl
clinic
outcom
therefor
longitudin
studi
test
reactiv
recipi
cell
donor
antigen
differ
time
point
need
nd
sb
jp
wrote
review
work
realiz
context
labex
igo
program
support
nation
research
agenc
via
invest
futur
program
labex
transplantex
context
ihucesti
project
receiv
french
govern
financi
support
manag
nation
research
agenc
via
invest
futur
program
context
centaur
foundat
ihucesti
project
also
support
nant
metropol
pay
de
la
loir
region
work
also
support
visicort
project
receiv
fund
european
union
seventh
framework
program
research
technolog
develop
demonstr
grant
agreement
thank
dr
yap
dr
haspot
fruit
discuss
